Axonal Guillain-Barré syndrome: concepts and controversies (Q28301911)

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Patterns of Guillain-Barre syndrome in children: results from a Mexican population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Acute motor conduction block neuropathy Another Guillain-Barre syndrome variant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Conduction block in acute motor axonal neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

An acute axonal form of Guillain-Barré polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Pitfalls in electrodiagnosis of Guillain-Barre syndrome subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Involvement of sensory fibres in axonal subtypes of Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Pathology of the motor-sensory axonal Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Sensory Nerve Conduction in Demyelinating and Axonal Guillain-Barré Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profile

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

The refractory period of transmission is impaired in axonal Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

The Guillain-Barré syndrome: a true case of molecular mimicry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Guillain-Barré syndrome subtypes related to Campylobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Validation of a rabbit model of neuropathy induced by immunization with gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Localization of major gangliosides in the PNS: implications for immune neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Structural requirements of anti-GD1a antibodies determine their target specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Neuromuscular transmission is not impaired in axonal Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Plasma exchange for Guillain-Barré syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Intravenous immunoglobulin therapy for Guillain-Barré syndrome with IgG anti-GM1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

Epidemiological study of Guillain-Barré syndrome in south east England

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970215-1

7 January 2021

10.1016/S1474-4422(13)70215-1

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24229616

1 reference

Consolidated OpenCitations Corpus – April 2017